# Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

> **NCT00684463** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 59 (actual)

## Conditions studied

- Neoplasms
- Nausea
- Vomiting

## Interventions

- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT00684463
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-11
- **Primary completion:** 2008-02-22
- **Final completion:** 2008-02-22
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684463, "Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00684463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*